Physician profile
Thomas B Rivers
NPI 1518963834
$7,214.15
in general payments reported to CMS, 2019-2025
12 companies · $1,572 in 2025
The $1,572 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $522 · 2021: $1,200 · 2022: $1,659 · 2023: $1,248 · 2024: $619 · 2025: $1,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,451 · Food and Beverage: $987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,451.44 |
| Food and Beverage | $986.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $3,053.06 | 2019-2025 | |
| Encore Medical, LP | $2,453.85 | 2022-2023 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $942.98 | 2024-2025 | Comprehensive Shoulder System |
| Stryker Corporation | $346.34 | 2022-2025 | Alphavent, Mako, Aequalis Perform Reversed |
| Arthrex, INC. | $303.20 | 2025 | |
| Orthalign INC | $27.06 | 2023 | Orthalign Plus |
| Innovation Technologies INC | $24.16 | 2024 | Irrisept |
| Abbott Laboratories | $19.85 | 2019 | |
| Depuy Synthes Sales INC. | $13.89 | 2025 | Orthovisc, Monovisc |
| Pacira Pharmaceuticals Incorporated | $13.17 | 2023 | Zilretta |
| Horizon Therapeutics Plc | $12.02 | 2019 | |
| Wound Management Technologies, INC | $4.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rivers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.